6 articles
Following the release of three-month interim findings1, the Ocular Surface Laboratory (OSL) team has now completed the full six-month analysis of a trial comparing handheld thermal pulsation therapy w
The Tear Film and Ocular Surface Society (TFOS) has a longstanding tradition of hosting its conferences in stunning locations worldwide, with the 2024 event taking place in Venice, Italy. Set against the picturesque backdrop of the Adriatic Sea, tear film and ocular surface specialists gathered from
Topical ivermectin 1.0% cream in the treatment of ocular demodicosisMartin Smith et al.Cont Lens Anterior Eye. 2024 Feb;47(1):102099 Review: This retrospective, single-centre study aimed to assess t
Participants in a trial using castor oil treatment for blepharitis were enthusiastic but solutions lie in the long game.
Inflammation plays a key role in triggering and propagating dry eye disease (DED) via the ‘vicious circle’1. In severe cases, topical anti-inflammatory therapy may be indicated, but managing a patient’s meibomian gland dysfunction can often be sufficient to resolve ocular surface inflammation withou
After successfully navigating Auckland’s extended Covid lockdown in 2021, the Ocular Surface Laboratory (OSL) team was excited to begin its long-awaited clinical trial to evaluate a single thermal pulsation treatment delivered by a novel handheld device (Systane iLux, Alcon) relative to standard-of-
